Results 3,641-3,660 of 3,699 for speaker:Lynn Ruane

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: If any of the witnesses wish, they may take that up.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: I thank Professor Comiskey and Deputy Shanahan. I am going to move on now to Deputy Quinlivan.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: This has been a great conversation so far. We need to extend prescription power to nurses. If we do not, it is a clear indication of a further stigmatisation. There is a kind of paternalistic idea that a nurse cannot determine a safe amount to prescribe. It means that where the healthcare service is working with an individual who needs methadone, there is suspicion off the bat. We are...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: That is what I thought. Perhaps there is a difference between a hospital setting and a primary care setting. Within the GP contract, a GP may be reimbursed. Do we know how much per annum per person a methadone patient would cost within a GP contract?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: That should be transparent. We do not want a situation whereby methadone patients do not receive the care they should be receiving while also being seen as an additional resource to a GP. That could inhibit the other professionals, such as nurses, stepping into that space and prescribing. I am interested in the rights-based approach. This is a bit of a side note, but I am thinking of...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: The rights-based stuff has already been established.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: It is about ensuring it is implemented across the professions and in the different sectors. I will go back for a moment to differentiating between methadone and morphine. Is there a stigmatisation of methadone? If methadone changed its name and was just called an opioid, would things be different? Methadone has become synonymous with a particular group. Can the witnesses explain the...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: I refer to the monopolisation, in one sense, of prescribing and the gatekeeping and the potential personalities driving that gatekeeping. Going back very briefly to the point about methadone and morphine, the methadone is slow release and longer acting. It is ticking along, whereas morphine can have much more of a flow in terms of its highs and lows. They are both of a similar nature and...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: I was trying to explain that in the context of a nurse prescribing morphine or methadone the precautions and assessments needed during their prescription. There would not be an increased risk in the assessment in the prescribing of methadone versus morphine.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: That is a mapping and follow-up issue with the person, rather than a clinical decision regarding the millilitres required or the safe dosage to give somebody in a particular setting or whatever.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: It is an economic decision as well, if the State wants to look at it as such. Does anyone have any final comments? As there will be a second session, I do not know if we have time for a full second round of questions, but any member who has outstanding questions may ask them.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: Does anyone want to make any final comments on any matters they were hoping we would cover?

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: If this committee comes out with anything that is not progressive, it will be against the evidence. That is how I will reframe that contribution.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: It has been an engaging session and very helpful, especially for homing in on some of the subjects that have not come up to date. It was specific and helpful. I thank Professor Comiskey, Dr. Kelly and Mr. McBrien.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: The witnesses are very welcome. It is positive to hear it reiterated that An Garda Síochána will support a health-led approach and that this approach will potentially - and hopefully in my view - be very different from the one proposed by the Department. It is not a health-led approach, as it is understood in terms of decriminalisation, from a legislative perspective. Policing or...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: It is that balance of police having a particular function in society in terms of control or detecting illegal activity and so on and having to change that culture somewhat. Changing that culture also can add to public safety in general. It is not necessarily about waiting outside tents or pulling people over as they go into a safe injection facility. Not doing that in fact extends, rather...

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: They were inflicting it on one another also. Even though they are in prison, the lives of those that are dead were also lost as they were caught up in it too. They become their own victims in a sense, which at times gets lost.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: I thank Mr. Kelly.

Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)

Lynn Ruane: I thank Mr. McBrien. I invite Professor Comiskey to make her opening statement.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Lynn Ruane: I thank the witnesses very much for their presentations. Obviously, 90% of those here are men. That is usually seen as a negative thing but it is a very positive thing when it comes to working with young men, especially in the communities we work in. It is especially positive to see working-class men who are experts not only because of their profession and education, but because of their...